Categories AlphaGraphs, Earnings, Health Care

ANGO Earnings: AngioDynamics swings to profit in Q4; revenues beat estimates

AngioDynamics Inc. (NASDAQ: ANGO) on Tuesday reported a modest profit for the fourth quarter of 2022 compared to breakeven last year. Revenues increased in double-digits and topped expectations.

AngioDynamics Q4 2022 earnings infographic

The medical device maker reported adjusted earnings of one cent during the three-month period, marking an improvement from the prior-year quarter when the bottom line was breakeven. The latest number came in line with the consensus estimates.

Revenues increased 13% year-over-year to $86.9 million in the May quarter and topped analysts’ forecast. The top line benefitted from strong performance by all three operating segments.

Check this space to read management/analysts’ comments on AngioDynamics’ Q4 2022 earnings

“We delivered on the strategic objectives for the fiscal year 2022 that we laid out a year ago during our Investor and Technology Day while managing through a number of macro-related headwinds, including supply chain disruptions and ongoing inflationary pressures. During our fourth quarter, we reduced our backlog as our manufacturing capacity improved, exiting the quarter more than 40% above the lows we experienced in December,” said AngioDynamics’ CEO Jim Clemmer.

Most Popular

TC BioPharm develops safer, less expensive products to target more cancers: CEO Bryan Kobel

TC BioPharm (NASDAQ: TCBP) is a clinical-stage cell therapy company focused on the development of treatments for infectious diseases, including advanced allogeneic chimeric antigen receptor (CAR) T-cell therapy products for

Cintas Corp. (CTAS) Q3 2023 earnings and revenue increase

Uniform rental company Cintas Corporation (NASDAQ: CTAS) on Wednesday announced financial results for the third quarter of 2023, reporting higher earnings and revenues. At $2.19 billion, third-quarter revenues were up

Infographic: Micron (MU) reports net loss for Q2; revenue down 53%

Micron Technology Inc. (NASDAQ: MU) slipped to a loss in the second quarter of 2023 from a profit last year, hurt by a sharp fall in revenues. The chipmaker reported

Add Comment
Viewing Highlight